Establishing successful university–industry collaborations: barriers and enablers deconstructed

• Published in: The Journal of technology transfer Vol. 48; no. 3; pp. 900 - 931
• Main Authors: O’Dwyer, Michele, Filieri, Raffaele, O’Malley, Lisa
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.06.2023; Springer Nature B.V
• Subjects: Business and Management; Collaboration; Commercial Law; Cooperation; Economic Growth; Evolution; Industrial Organization; Innovation/Technology Management; Management; Pharmaceutical industry; Pharmaceuticals; Qualitative research; R&D; Research & development; Collaboration barriers; Government funding; University–industry networks; Collaboration enablers
• ISSN: 0892-9912; 0892-9912; 1573-7047
• DOI: 10.1007/s10961-022-09932-2

University–Industry Collaboration networks are increasingly significant to national economies. Previous studies have identified barriers and enablers of University–Industry Collaborations, however our understanding of the evolution of such collaborations is still limited thereby restricting our ability to nurture their development. This study explores the establishment of a successful University–Industry Collaboration and considers a range of perceived barriers and enablers through four emergent evolutionary phases: embryonic, initiation, engagement and established . The study adopted a qualitative research approach using a single site case study, focusing on the pharmaceutical industry, with 10 multinational firms and 8 academic institutions involved in a pharmaceutical collaboration. The results demonstrate that specific University–Industry Collaboration barriers and enablers emerge at different points in time, for example, strong lack of trust; strong fear of knowledge leakage, reluctance to share in the embryonic phase evolve to achieving integrity based trust and an intellectual property agreement in the engagement phase. These barriers were overcome using a range of phase appropriate mechanisms, for example, prior experience of the partners was critical in the embryonic phase, while cohesiveness and knowledge complementarity were vital in the engagement phase. The study emphasizes the significance of public funding and its distribution among members in order to support industry evolution and competitiveness. The University–Industry Collaboration continues to attract new participants and additional network-specific investments and has become a global centre of excellence for pharmaceutical research and development.